全文获取类型
收费全文 | 311446篇 |
免费 | 28512篇 |
国内免费 | 13071篇 |
专业分类
耳鼻咽喉 | 2661篇 |
儿科学 | 3965篇 |
妇产科学 | 3797篇 |
基础医学 | 60603篇 |
口腔科学 | 6936篇 |
临床医学 | 21987篇 |
内科学 | 50893篇 |
皮肤病学 | 4889篇 |
神经病学 | 24495篇 |
特种医学 | 6304篇 |
外国民族医学 | 78篇 |
外科学 | 23101篇 |
综合类 | 42186篇 |
现状与发展 | 45篇 |
一般理论 | 8篇 |
预防医学 | 13357篇 |
眼科学 | 5481篇 |
药学 | 43092篇 |
61篇 | |
中国医学 | 11267篇 |
肿瘤学 | 27823篇 |
出版年
2024年 | 545篇 |
2023年 | 4684篇 |
2022年 | 9732篇 |
2021年 | 14162篇 |
2020年 | 11008篇 |
2019年 | 9651篇 |
2018年 | 9547篇 |
2017年 | 10121篇 |
2016年 | 10644篇 |
2015年 | 12454篇 |
2014年 | 18720篇 |
2013年 | 21666篇 |
2012年 | 18205篇 |
2011年 | 20973篇 |
2010年 | 17416篇 |
2009年 | 17250篇 |
2008年 | 17403篇 |
2007年 | 16142篇 |
2006年 | 14511篇 |
2005年 | 12635篇 |
2004年 | 10641篇 |
2003年 | 9285篇 |
2002年 | 7249篇 |
2001年 | 6045篇 |
2000年 | 5132篇 |
1999年 | 4582篇 |
1998年 | 4379篇 |
1997年 | 4069篇 |
1996年 | 3588篇 |
1995年 | 3368篇 |
1994年 | 3016篇 |
1993年 | 2671篇 |
1992年 | 2234篇 |
1991年 | 2096篇 |
1990年 | 1775篇 |
1989年 | 1576篇 |
1988年 | 1454篇 |
1987年 | 1267篇 |
1986年 | 1200篇 |
1985年 | 1728篇 |
1984年 | 1579篇 |
1983年 | 1125篇 |
1982年 | 1223篇 |
1981年 | 971篇 |
1980年 | 826篇 |
1979年 | 684篇 |
1978年 | 455篇 |
1977年 | 363篇 |
1976年 | 336篇 |
1975年 | 179篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
171.
172.
To determine the protective effect of aloe-emodin (AE) from high glucose induced toxicity in RIN-5F (pancreatic β-cell) cell and restoration of its function was analyzed. RIN-5F cells have been cultured in high glucose (25 mM glucose) condition, with and without AE treatment. RIN-5F cells cultured in high glucose decreased cell viability and increased ROS levels after 48 hr compared with standard medium (5.5 mM glucose). Glucotoxicity was confirmed by significantly increased ROS production, increased pro-inflammatory (IFN-γ, IL-1β,) & decreased anti-inflammatory (IL-6&IL-10) cytokine levels, increased DNA fragmentation. In addition, we found increased Bax, caspase 3, Fadd, and Fas and significantly reduced Bcl-2 expression after 48 hr. RIN-5F treated with both high glucose and AE (20 μM) decreased ROS generation and prevent RIN-5F cell from glucotoxicity. In addition, AE treated cells cultured in high glucose were transferred to standard medium, normal responsiveness to glucose was restored within 8hr and normal basal insulin release within 24 hr was achieved when compared to high glucose. 相似文献
173.
174.
Understanding the contribution of endothelial cells to the progenitor pools of adult tissues has the potential to inform therapies for human disease.To address whether endothelial cells transdifferentiate into non-vascular cell types,we performed cell lineage tracing analysis using transgenic mice engineered to express a fluorescent marker following activation by tamoxifen in vascular endothelial cadherin promoter-expressing cells(VEcad-CreERT2;B6 Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze).Activation of target-cell labeling following 1.5 months of ad libitum feeding with tamoxifen-laden chow in 4–5 month-old mice resulted in the tracing of central nervous system and peripheral cells that include:cerebellar granule neurons,ependymal cells,skeletal myocytes,pancreatic beta cells,pancreatic acinar cells,tubular cells in the renal cortex,duodenal crypt cells,ileal crypt cells,and hair follicle stem cells.As Nestin expression has been reported in a subset of endothelial cells,Nes-CreERT2 mice were also utilized in these conditions.The tracing of cells in adult Nes-CreERT2 mice revealed the labeling of canonical progeny cell types such as hippocampal and olfactory granule neurons as well as ependymal cells.Interestingly,Nestin tracing also labeled skeletal myocytes,ileal crypt cells,and sparsely marked cerebellar granule neurons.Our findings provide support for endothelial cells as active contributors to adult tissue progenitor pools.This information could be of particular significance for the intravenous delivery of therapeutics to downstream endothelial-derived cellular targets.The animal experiments were approved by the Boise State University Institute Animal Care and Use Committee(approval No.006-AC15-018)on October 31,2018. 相似文献
175.
目的 探讨血清谷丙转氨酶(ALT)与新诊2型糖尿病(T2DM)患病风险之间的关联,为T2DM的防治提供科学依据。方法 采用4阶段分层随机抽样的方法选取2006年和2009年参与青岛糖尿病预防项目的研究对象男性3 012例、女性4 422例,采用Pearson相关检验分析不同性别ALT与FPG、2 h PG的相关性,并利用多因素logistic回归分析ALT与新诊T2DM患病的关系。结果 男性中,ALT与空腹血浆血糖(FPG)、餐后2 h血浆血糖(2 h PG)的Pearson相关系数分别为0.088、0.080(均P<0.01);多因素logistic回归显示,在调整了年龄、BMI、糖尿病家族史、城乡、教育、婚姻、收入、吸烟及饮酒状况等混杂因素后,ALT的第4分位(Q4)组新诊T2DM患病风险是第1分位(Q1)组的1.832倍(OR = 1.832,95% CI:1.324~2.534,P<0.01)。女性中,ALT与FPG、2h PG的Pearson相关系数分别为0.065、0.108(均P<0.01);多因素logistic回归显示,在调整了年龄、BMI、糖尿病家族史、城乡、教育、婚姻、收入、吸烟及饮酒状况等混杂因素后,ALT的第4分位(Q4)组新诊T2DM患病风险是第1分位(Q1)组的1.445倍(OR = 1.445,95% CI:1.087~1.919,P<0.05)。结论 在男、女性人群中,ALT水平升高与T2DM患病相关,且这种相关性不受年龄、BMI、糖尿病家族史等的影响。 相似文献
176.
F. Murina R. Felice S. Di Francesco L. Nelvastellio I. Cetin 《Gynecological endocrinology》2020,36(5):431-435
AbstractThis study is a single-center, retrospective analysis of postmenopausal women presenting with dyspareunia and vulvar pain, aiming to evaluate relative effectiveness of vestibular CO2 laser therapy as a treatment. Three monthly sessions of laser were performed to each patient and thereafter a three-months follow-up was stablished. A total number of 72 patients undergoing vestibular laser treatment were recruited from patient files in the period between 2016 and 2018. Among these, 39 women also received a concomitant treatment with ospemifene (60?mg/day) during the study period. There was a statistically significant reduction of all the symptoms in both groups up to the three month follow-up. Regarding dryness and dyspareunia, the relief tent to be more prominent in the ospemifene?+?laser group at all follow-ups and remained statistically significant at three-month follow-up. Specifically, vestibular dryness was significantly lower in the ospemifene?+?laser group compared with the laser treatment group (?87% vs???34%, respectively), and the vestibular health score started declining faster in the ospemifene?+?laser group. Although, additional research is needed to understand the mechanism of action, our data shows that a combination regimen of laser and ospemifene may improve clinical effectiveness for long-term treatment of symptoms associated with the under-recognized genitourinary syndrome of menopause. 相似文献
177.
178.
179.
180.